Weight-loss drug Wegovy approved by FDA to cut heart attack, stroke risk

The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday.The Food and Drug Administration approved a label change requested by drugmaker Novo Nordisk that expands the use of semaglutide.The decision was based on the results of a study that found that Wegovy cut the risk of serious heart problem ...